Chamath Palihapitiya - 11 Jul 2022 Form 4/A - Amendment Insider Report for PROKIDNEY CORP. (PROK)

Role
10%+ Owner
Signature
/s/ James Ryans, as attorney-in-fact
Issuer symbol
PROK
Transactions as of
11 Jul 2022
Net transactions value
+$125,000,000
Form type
4/A - Amendment
Filing time
20 Jul 2022, 16:32:20 UTC
Date Of Original Report
13 Jul 2022
Previous filing
24 Nov 2021
Next filing
23 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PROK Class A ordinary shares Award $95,000,000 +9,500,000 +1484% $10.00 10,140,000 11 Jul 2022 See footnote F1, F2
transaction PROK Class A ordinary shares Award $30,000,000 +3,000,000 +30% $10.00 13,140,000 11 Jul 2022 See footnote F1, F3
transaction PROK Class A ordinary shares Options Exercise $0 +6,220,000 +47% $0.000000 19,360,000 11 Jul 2022 See footnote F4, F5
transaction PROK Class A ordinary shares Other $0 -3,087,000 -16% $0.000000 16,273,000 11 Jul 2022 See footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Class B ordinary shares Options Exercise $0 -6,220,000 -100% $0.000000* 0 11 Jul 2022 Class A ordinary shares 6,220,000 See footnote F4, F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4, filed on July 13, 2022, is being amended by this amendment to (i) correct an administrative error which reported the aggregate amount of Class A ordinary shares ("shares") purchased by SC PIPE Holdings LLC ("PIPE Holdings") as 9,000,000 shares instead of 9,500,000 shares and (ii) report an indirect interest in shares purchased by a trust for the benefit of members of Mr. Palihapitiya's immediate family, as discussed in footnote 3 below.
F2 Represents shares purchased by PIPE Holdings in connection with the consummation of the business combination between the issuer and ProKidney LP (the "Business Combination"). PIPE Holdings is controlled by Mr. Palihapitiya. Mr. Palihapitiya may be deemed to beneficially own shares held by PIPE Holdings by virtue of his indirect interests in PIPE Holdings or his control over PIPE Holdings, as the case may be.
F3 Represents shares purchased by a trust for the benefit of Mr. Palihapitiya's immediate family in connection with the consummation of the Business Combination.
F4 The Class B ordinary shares held by SCS Sponsor III LLC (the "Sponsor") converted to shares on a one-for-one basis upon the consummation of the Business Combination.
F5 The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, which is controlled by Mr. Palihapitiya. Mr. Palihapitiya may be deemed to beneficially own shares held by the Sponsor by virtue of his indirect interests in the Sponsor or his shared control over the Sponsor, as the case may be.
F6 Represents the distribution for no consideration by the Sponsor of 6,860,000 shares to its members pro rata in accordance with their respective interests (the "Sponsor Distribution"). SC Master Holdings, LLC ("Master Holdings"), received 3,773,000 shares in the Sponsor Distribution. Master Holdings is controlled by Mr. Palihapitiya. Mr. Palihapitiya may be deemed to beneficially own shares held by Master Holdings by virtue of his indirect interests in Master Holdings or his control over Master Holdings, as the case may be.
F7 The Class B ordinary shares were automatically convertible into shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date.

Remarks:

The inclusion of the securities in this report shall not be deemed an admission by the reporting person of beneficial ownership of all of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose or that any of the transactions reported herein are subject to Section 16.